Incregen Therapeutics Selected for Leading Healthcare Innovation Program
PR Newswire —
Incregen Therapeutics, a privately held biotechnology company focused on developing novel therapies for obesity and related metabolic disease, today announced the company's selection by the Mayo Clinic Berg Innovation Exchange to become a member. Invitation for membership provides unique...